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Lysosomes maintain immune homeostasis through the degradation of phagocytosed apoptotic debris; however, the signaling events
regulating lysosomalmaturation remain undefined. In this study, we show that lysosome acidification, key to thematuration process,
relies onmTOR complex 2 (mTORC2), activation of caspase-1, and cleavage of Rab39a.Mechanistically, the localization of cofilin to
the phagosome recruits caspase-11, which results in the localized activation of caspase-1. Caspase-1 subsequently cleaves Rab39a on
the phagosomal membrane, promoting lysosome acidification. Although caspase-1 is critical for lysosome acidification, its activation
is independent of inflammasomes and cell death mediated by apoptosis-associated speck-like protein containing a caspase recruit-
ment domain, revealing a role beyond pyroptosis. In lupus-prone murine macrophages, chronic mTORC2 activity decouples the
signaling pathway, leaving Rab39a intact. As a result, the lysosome does not acidify, and degradation is impaired, thereby
heightening the burden of immune complexes that activate FcgRI and sustain mTORC2 activity. This feedforward loop promotes
chronic immune activation, leading to multiple lupus-associated pathologies. In summary, these findings identify the key molecules
in a previously unappreciated signaling pathway that promote lysosome acidification. It also shows that this pathway is disrupted
in systemic lupus erythematosus. The Journal of Immunology, 2018, 201: 371–382.
E
xtracellular cargo can be internalized through endocy-
tosis, phagocytosis, or LC3A-associated phagocytosis
(LAP). Following internalization, the exchange of small
Rab GTPases on vesicular membranes dictates trafficking (1),
whereas ESCRT proteins associated with ubiquitinated proteins/
receptors on vesicular membranes promote lysosomal degradation
(2). Following the fusion of phagosomes with lysosomes, re-
cruitment of LAMP proteins stabilizes the membrane (3), and
assembly of the vacuolar H+-ATPase (V-ATPase) facilitates
acidification (4). Although phagosomal maturation requires the
association of numerous proteins, fundamentally it is a two-step
process. First, assembly of the NADPH oxidase on the phag-
osomal membrane initiates the oxidative burst that transfers
electrons to molecular oxygen-producing reactive oxygen species
(5). Second, termination of the oxidative burst and assembly of the
V-ATPase acidifies the phagosome, activating hydrolytic enzymes
that degrade internalized cargo (6).
Proteins not directly involved in vesicular trafficking also
influence lysosomal degradation. During infection, microbes
manipulate ARP2/3 and cofilin, thereby dysregulating the
actin cytoskeleton, resulting in lysosome collapse and altered
phagosome–lysosome fusion (7, 8). Further, caspase-1 and cas-
pase-11 are critical for lysosome acidification following phago-
cytosis of Staphylococcus aureus and Legionella pneumophila
(9, 10). Also, mammalian target of rapamycin (mTOR) associates
with the lysosome and senses amino acid levels through an “in-
side-out” mechanism (11). How the actin cytoskeleton, pyroptotic
caspases, and mTOR influence lysosome function remains unclear.
Despite an incomplete understanding of the events controlling
lysosome function, many diseases are associated with lysosomal
defects, including cardiovascular disease, cancer, and neuro-
degeneration (12). In addition, we recently reported that lysosome
maturation is defective in systemic lupus erythematosus (SLE),
in which macrophages (Mws) fail to degrade immune complexes
(ICs) formed by IgG binding to apoptotic blebs (IgG-ICs) (13).
Coincident with elevated FcgRI signal transduction (14), intact
IgG-ICs are recycled to the cell membrane bound to FcgRs where
they accumulate (13). Accumulation of nuclear Ags on the surface
of the immune cells occurs prior to SLE-associated pathologies in
MRL/lpr mice (14), and impaired degradation of IgG-ICs
heightens BAFF, IFN-a, autoantibodies, cell death, B cell ex-
pansion, and lupus nephritis (13–15). Additionally, accumulation
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of IgG-ICs is found in other murine models of SLE, including
NZM2410 (13, 14). This supports a model in which lysosome
defects promote inflammation during SLE pathogenesis. There-
fore, impaired lysosomal maturation in lupus-prone Mws provides
a disease-relevant model to identify signaling events associated
with lysosome maturation.
This study reveals that the cleavage of Rab39a by locally ac-
tivated caspase-1 occurs on the surface of phagocytic vesicles and
is necessary for lysosome acidification. This process requires
cofilin association with the actin that surrounds the vesicle and
recruits caspase-11, which locally activates caspase-1. In turn,
caspase-1 cleaves Rab39a to promote lysosome acidification. In
lupus-prone Mws, this cascade is defective because chronically
active mTOR complex 2 (mTORC2) heightens cofilin phosphor-
ylation, thereby disrupting its binding to actin, a critical early step
in the pathway to acidification. As a consequence, caspase-11 is
not recruited to the vesicle, the localized activation of caspase-1 is
reduced, Rab39a is not cleaved, and the lysosome does not fully
acidify. By using a disease model harboring defects in lysosome
maturation, we define the key molecules in a previously unap-




C57BL/6J (B6) and MRL/MpJ-Tnfrs6lpr/J (MRL.Faslpr; MRL/lpr; JAX
mice stock no. 000485) colonies were maintained in an accredited animal
facility. The B6.caspase-12/2 (Casp12/2) (16), B6.caspase-12/2caspase-
112/2 (Casp12/2Casp112/2) (17), and B6.pycard2/2 (18) mice were
obtained from Dr. E. Miao. The B6.caspase-12/2caspase-11tg (16) mice
were obtained from Dr. J. Ting. FcgRI2/2MRL/lpr and AID2/2MRL/lpr
mice were previously described (14).
Reagents
Abs specific for CD11b were from BD Biosciences; ribosomal protein S6
(rpS6), p-rpS6, p-AktS473, p-AktT308, Akt, 59 AMP-activated protein
kinase (AMPK), p-AMPK, tubulin, mTOR, LC3A, p-cofilin, cofilin,
caspase-11, and FLAG were from Cell Signaling Technology; caspase-1
was from Genentech; HAwas from Abcam; CD40, CD80, and anti-rabbit
IgG were from BioLegend Pharmaceuticals; anti-goat and -rabbit (Alexa
647) IgG were from Molecular Probes; Concanamycin A was from
Sigma-Aldrich; LimKi 3 and Jasplakinolide (JasP) were from EMD
Calbiochem; Torin1 was from Tocris Bioscience; rapamycin was from
Cell Signaling Technology; IRDye680- and IRDy800-conjugated Abs
(anti-rabbit, anti-mouse) were from LI-COR Biosciences; phalloidin and
LysoSensor Yellow/Blue dextran were from Thermo Fisher; streptavidin
(PE) was from Jackson ImmunoResearch; and FAM-FLICA Caspase-1
Assay Kit was from ImmunoChemistry Technologies. Abs specific to
nucleosome (PL2-3), Smith (2.12.3), and CD16/32 (2.4G2) and L cell
media (LCM) for bone marrow Mw (BMMw) differentiation were gen-
erated as previously described (13).
BMMw cultures
BMMws from 6- to 10-wk-old mice (prior to the onset of disease) were
derived as previously described (13), with the exception that cells
derived for 5 d (rather than 7) were grown in 15% LCM (rather than
10%) to accelerate differentiation. Increasing the concentration of
M-CSF increased the rate of Mw differentiation while maintaining
comparable levels of CD11b, CD40, and CD80. BMMws cultured in
15% LCM for 5 d or 10% LCM for 7 d were 90–98% CD11b+, I-Alo,
and B7.2lo.
Formation of ICs
Apoptotic cells from irradiated thymocytes were pelleted (5 min 350 3 g).
To form apoptotic cells opsonized by IgG (WC-ICs), the pellets were
resuspended in 2.5 ml of R10 (RPMI 1640 with 10% FBS). To form IgG-
ICs, the supernatant-containing apoptotic blebs were recovered (13).
Whole apoptotic cells (1 ml of resuspended pellet) or apoptotic blebs (1 ml
of supernatant) were cultured with IgG (6.67 mg) at 4˚C for 75 min to form
WC-ICs or IgG-ICs, respectively.
Fluorescent microscopy
BMMws were cultured with IgG-ICs (Alexa 647) in R10 media for 2 h at
37˚C, fixed with 2% paraformaldehyde at 4˚C for 15 min, blocked in
2.4G2 (FcgR block) for 30 min at 4˚C in FACS media (PBS with 2% FBS,
0.02% NaN3), washed, and then stained with primary and secondary Abs,
or nuclear-stained with Hoechst 33342 (1mg/ml), in permeabilization
buffer (PBS with 0.05% saponin and 0.5% BSA) for 30 min at 4˚C. Mws
attached to glass-bottom dishes were imaged in FACS media, whereas
unattached Mws were resuspended in FluorSave. All confocal microscopy
used a Zeiss 710 confocal microscope with a 63 3 1.4 numerical aperture
(oil) Plan Apo lens and Zeiss Zen Software. Images were analyzed using
ImageJ. Colocalization was measured by calculating the Mander’s overlap
coefficient (colocalized pixels/total fluorescent pixels).
Cellular motility assays
BMMws were plated onto glass coverslips for 48 h. To quantify membrane
ruffling, a kymograph (perpendicular to the cell membrane) was generated
for each cell. The persistence and average velocity for membrane extension
and retraction were measured. For migration, BMMws were plated onto
fibronectin-coated glass coverslips for 24 h. The percentage of migrating
cells was quantified per field of view over a 2-h time course. Average ve-
locity and persistence of migration were quantified for each migrating cell.
Flow cytometry
BMMws were warmed (37˚C, 5% CO2) for 2 h prior to the addition of
40 ml of IgG-ICs in R10 media (as above). To quantify pH in a cell that had
not acidified, concanamycin A (20 ng/ml) was introduced to one sample
from each treatment and/or background 1 h prior to addition of IgG-ICs
and then left on the cells throughout the experiment. IgG-ICs and Lyso-
Sensor (2 mg/ml) were cocultured with the BMMws for 30 min, cells were
pelleted, and media was replaced with fresh rhodamine-free R10 media.
Cells were incubated for the indicated time points and then analyzed by
flow cytometry. The dye was excited with a UV laser (355 nm). Relative
pH was quantified by calculating the ratio of the median fluorescence
intensity (MFI) from the emission channels (450/20, 585/42 nm) and
normalized to the concanamycin A–treated control. Absolute pH was
estimated from the ratio of the emission channels by establishing a cali-
bration curve (13). In this study, identical samples were analyzed by flow
cytometry and confocal microscopy against solutions of known pH. A ratio
of 1 corresponded to a basal pH of 6.7, ratios of 0.6–0.7 corresponded to a
pH of 4, and ratios of 0.85–0.95 corresponded to a pH of 5.5–6.
To analyze surface and intracellular proteins in BMMws, harvested cells
were resuspended in FACS media and stained (as above), and the MFI of
the indicated proteins was determined by flow cytometry and normalized
to an isotype control. All flow cytometry was conducted using an 18-color
BD LSR II flow cytometer, and data were acquired using BD FACSDiva
8.0.1 software.
Immunoprecipitation and immunoblot
Cells were lysed in buffer containing 1% CHAPS, 150 mM NaCl, 10 mM
Tris (pH 7.5), 2 mM sodium orthovanadate, 1 mM PMSF, 0.4 mM EDTA,
10 mM NaF, and 1 mg/ml (each) aprotinin, leupeptin, and a-1–antitrypsin
and were then held on ice for 10 min followed by the removal of partic-
ulate material by centrifugation at 12,000 3 g for 10 min at 4˚C. Immu-
noprecipitating Abs were conjugated to cyanogen bromide–activated
Sepharose 4B per the manufacturer’s instructions (Amersham Pharmacia
Biotech). Approximately 2 mg of precipitating Ab was incubated with
1.5 3 106 cell equivalents of cleared lysate for 2 h at 4˚C. Immunopre-
cipitates were washed, resuspended in reducing SDS-PAGE sample buffer,
and then fractionated by 10 or 15% SDS-PAGE. Separated proteins were
transferred to Immobilon-FLMembranes, blocked in LI-COR Blocking Buffer,
and then incubated with the various immunoblotting Abs and fluorophore-
conjugated secondary Abs. Immunoreactive proteins were detected using a
LI-COR Odyssey Infrared Imaging System with Odyssey 3.0 software.
Generation of Rab39a plasmids
Wild type Rab39a– and Rab39aD148A–containing, N-terminal HA and
C-terminal FLAG epitopes (primers: Rab39a forward and Rab39a reverse),
and the Rab39a N-terminal (Rab39a[NT]) (primers: Rab39a forward and
Rab39a[NT] reverse) and Rab39a C-terminal (Rab39a[CT]) (primers:
Rab39a[CT] forward and Rab39a reverse) constructs were amplified from
pMXsIG mRAb39a wt plasmid and pMXsIG mRab39a mut plasmid. The
amplified products were cloned into pCDNA3.1/V5-His digested with
BamHI and XhoI using Gibson (New England BioLabs) cloning, and se-
quences were confirmed.
Consistent with ex vivo Mws (14), these data indicate that FcgRI
signaling underlies chronic PI3K and mTORC2 activity and
contributes to mTORC1 activity.
The subcellular location of mTOR is critical for balancing cell
growth and nutrient availability. For example, localization of
mTOR at the cell membrane is important for insulin signaling and
cytoskeletal rearrangements (25, 26), whereas localization to ly-
sosomal membranes is important in amino acid sensing (11). In
MRL/lpr Mws, there was 3.5-fold more mTOR localized to the cell
membrane compared with B6 (Fig. 1C, 1D). This difference was
not due to heightened mTOR expression (Fig. 1E). Rather, it reflects
mTOR activity because inhibiting mTORC1 and mTORC2
(mTORC1/C2) with Torin1 (27) reduced mTOR localization to the
cell membrane (Fig. 1C, 1D). In addition, staining for RICTOR
(mTORC2) and RAPTOR (mTORC1) revealed comparable locali-
zation at the membrane in B6 and MRL/lpr Mws (Supplemental
Fig. 1C–E). Treatment with Torin1 did not displace RICTOR or
RAPTOR from the membrane of either B6 or MRL/lpr BMMws,
suggesting that localization of RICTOR and RAPTOR at the
membrane is independent of activity. Thus, the chronic localization
of active mTOR at the cell membrane likely consists of both
RICTOR and RAPTOR complexes localized to PIP3 (25, 26).
To assess whether chronic mislocalization of mTOR at the cell
membrane disrupts lysosome acidification, we measured the pH of
the vesicles containing IgG-ICs. For these experiments, we used
LysoSensor Yellow/Blue dextran. This dye is internalized with
IgG-ICs during phagocytosis, and the conjugation to dextran re-
stricts the dye to the phagosome. This allows for specific quanti-
fication of phagosome acidification during maturation and fusion
with the lysosome. Using single-cell microscopy with standards,
we previously demonstrated that B6 Mws treated with a V-ATPase
inhibitor exhibit a basal pH = 6.7 (13). Following phagocytosis of
IgG-ICs, B6 Mws acidify to a pH of 4 (13). For ratiometric flow
cytometry, we normalized the unacidified phagosome (pH = 6.7)
to 1, with a pH of 4 corresponding to a relative pH of 0.6–0.7 (13).
In contrast, MRL/lpr Mws failed to sustain a pH below 5.5 cor-
responding to a relative pH ranging from 0.85–0.95 (13). Con-
sistent with our previous study, stimulating B6 Mws with IgG-ICs
induced a 22% decrease in vesicular pH (pH # 4.5) within 30 min
(Fig. 2A, gating scheme in Supplemental Fig. 1F). In contrast,
MRL/lpr Mws showed an 8% decrease in pH (pH $ 5.5), in-
dicating lysosome acidification is impaired. The inability of
MRL/lpr Mws to acidify lysosomes is the result of mTOR activity
because treatment with Torin1 restored acidification to levels
comparable to B6 (Fig. 2A).
Previously, we reported that diminished lysosome acidification
promotes the recycling of IgG-ICs because hydrolase activity is
reduced at a suboptimal pH (13). Coinciding with restored lyso-
some acidification, Torin1 treatment prevented MRL/lpr Mws
from recycling IgG-ICs to the cell membrane (Fig. 2B). In B6
Mws, Torin1 treatment also reduced the basal level of IgG-IC
recycling, suggesting that inhibition of mTORC1/C2 broadly en-
hances the degradative capacity of the lysosome. To decipher
whether mTORC1 and/or mTORC2 were important in lysosome
acidification, we compared treatment with Torin1 to rapamycin; a
potent inhibitor of mTORC1 (28). In MRL/lpr Mws, treatment
with rapamycin inhibited mTORC1, whereas treatment with
Torin1 inhibited the activity of mTORC1/C2 (Supplemental Fig.
1G). Unlike Torin1, rapamycin treatment was not sufficient in
restoring lysosome acidification in MRL/lprMws (Fig. 2A). These
data suggest a specific role for mTORC2 in lysosome acidifica-
tion. Because autophagy is inhibited by mTORC1 activity (29),
and rapamycin (mTORC1 inhibitor) did not restore acidification
(Fig. 2A), it is unlikely that autophagy is involved in degrading
The PCR primers used to generate Rab39a include: Rab39a forward: 59-
GGATCTAGCTAGTTAATTAAGGATCCGCCATGTACCCATACGATG-
TTCCAGATTACGCTATGGAGACTATTTGGATCTATC-39 and Rab39a 
reverse: 59-GGCGCGCCGGCCCTCGAGTCACTTGTCGTCATCG-
TCTTTGTAGTCACAGAAGCACTCTTT-39. The PCR primers used to 
generate the N- and C-terminal fragments of Rab39a include: Rab39a CT 
forward: 59-GGATCTAGCTAGTTAATTAAGGATCCGCCATGTGTGG-
AATGAAGTACATAGA-39 and Rab39a NT reverse: 59- GGCGCGCCG-
GCCCTCGAGTCATTAGTCTGTTGACAGTCTTTCAGC-39.
Retroviral transduction
Platinum-E Retroviral Packaging Cells were used to create retroviral 
particles containing Rab39a constructs per the manufacturer’s instructions 
(Cell Biolabs, San Diego, CA). During derivation, Mws were transduced 
on day 2 using 200 ml of BMMw media (15% LCM) + polybrene (5 mg/ml) 
in a 24-well low-cluster plate (37˚C, 5% CO2). After 6 h, 1 ml of BMMw 
media (15% LCM) was added to each well, and the cells were cultured for 
another 3 d. By day 5, BMMws were fully derived, and transduced cells 
(10–14% of CD11b+ cells) predictably expressed HA and FLAG only 
when the corresponding N- or C-terminal fragment was present.
Statistics
For microscopy-based experiments, representative images are provided 
along with quantification of all cells imaged. Error bars represent variation 
between cells (mean). Error bars in all other assays represent the variation 
between mice (mean). All p values were calculated using an unpaired t test, 
one-way ANOVA (Newman–Keuls posttest), or two-way ANOVA when 
applicable. Significance is indicated on the graphs as follows: p . 0.05 
(not significant), *p # 0.05, **p # 0.01, and ***p # 0.001.
Results
Chronic mTORC2 activity prevents lysosome acidification
Lupus-prone MRL/MpJ-Tnfrs6lpr/J (MRL.Faslpr; MRL/lpr) mice 
develop spontaneous autoimmunity characterized by the produc-
tion of autoreactive Abs and glomerulonephritis (19). Although 
the Fas lpr deficiency accelerates autoimmunity, the MRL back-
ground confers the accumulation of surface-bound IgG-ICs, in 
part, bound to FcgRI (14, 15). To assess whether FcgRI signaling 
is chronically activated in MRL/lpr Mws, we quantified phos-
phorylated signaling effectors downstream of FcgRI (20). Phos-
phorylation of rpS6 reflects the activity of mTORC1 (21). Prior to 
stimulation with IgG-ICs, BMMws derived from lupus-prone 
MRL/lpr mice exhibited a 5.3-fold increase in p-rpS6 compared 
with BMMws from B6 mice (Fig. 1A, 1B). Following stimulation 
with IgG-ICs, the levels of p-rpS6 in MRL/lpr Mws remained 
4.8-fold higher than B6, indicating chronically active mTORC1. 
mTORC2 and PI3K activity are upstream of p-AktS473 and 
p-AktT308, respectively (22, 23). Unstimulated MRL/lpr Mws 
exhibited 3.4- and 3.1-fold increases in basal levels of these 
effectors compared with B6 cells. Following stimulation with 
IgG-ICs, MRL/lpr Mws retained a 2.3- and 2.5-fold increase in
p-AktS473 and p-AktT308, suggesting that mTORC2 and PI3K are 
chronically active in MRL/lpr Mws (Fig. 1A, 1B, Supplemental 
Fig. 1A, 1B).
To assess whether the activation of the PI3K/Akt/mTOR path-
way in MRL/lpr Mws derived from FcgRI, we assessed the levels 
of these effectors in BMMws from FcgRI2/2MRL/lpr mice. We 
found that BMMws from FcgRI2/2MRL/lpr mice exhibited levels 
of p-AktS473/T308 that were comparable to B6 (Fig. 1A, 1B). This 
implicates FcgRI signal transduction in heightened activation of 
mTORC2 and PI3K in MRL/lpr mice. In contrast, the increased 
mTORC1 activity (as measured by rpS6 phosphorylation) was 
reduced only 2.4-fold in FcgRI2/2MRL/lpr Mws compared with 
MRL/lpr (Fig. 1A, 1B), suggesting receptors other than FcgRI are 
involved in mTORC1 activation, possibly through a MEK/ERK-
dependent process (24). Elevated p-rpS6 levels were not depen-
dent on AMPK because p-AMPK and total AMPK levels were 
not different in MRL/lpr BMMws (Supplemental Fig. 1A, 1B).
IgG-IC. This is consistent with our previous study showing that
,5% of internalized IgG-ICs enter autophagosomal structures (13).
To determine whether the role of mTORC2 in lysosome acidi-
fication is unique to phagocytosis, we assessed an alternative form of
internalization called LAP (30). Upon phagocytosis of large cargo
(e.g., intact apoptotic cells) LC3A stabilizes the phagosomal
membrane to form a LAPosomal structure. To assess LAP, we
measured the levels of LC3A in Mws following exposure to intact
WC-ICs. Phagocytosis of WC-ICs increased LC3A levels 3.5- to
3.1-fold in B6 and MRL/lpr Mws, an effect not seen post-
phagocytosis of IgG-ICs (Fig. 2C). In addition, intact apoptotic cells
(no IgG) also increased LC3A (Supplemental Fig. 1H), indicating
that LAP is not influenced by IgG and might occur because of cargo
size. To assess whether MRL/lpr Mws exhibit defective lysosome
acidification following LAP and whether this process is similarly
influenced by mTORC2, we monitored vesicular pH following
phagocytosis of WC-ICs. Although WC-ICs required more time to
induce acidification (Fig. 2D) compared with IgG-ICs (Fig. 2A), the
magnitude of lysosome acidification was comparable. As with IgG-
ICs, phagocytosis of WC-ICs failed to promote acidification in
MRL/lprMws, and diminished acidification following LAP was not
due to decreased LC3A expression, as these levels were comparable
in MRL/lpr and B6 Mws (Fig. 2C). To determine whether mTORC2
plays a similar role during LAP, we treated MRL/lpr Mws with
Torin1 or rapamycin. Torin1 restored lysosome acidification in
MRL/lpr Mws to levels comparable to B6, whereas rapamycin had
no effect (Fig. 2D). These data demonstrate that chronic mTORC2
activity impairs lysosome acidification, regardless of the means of
internalization. Further, these data raise the possibility that lupus-
related pathologies associated with impaired LAP (31) could result
from impaired lysosome maturation (13–15).
Chronic mTORC2 activity phosphorylates and
mislocalizes cofilin
mTORC2 regulates actin dynamics by activating Rho GTPases (28)
that, in turn, stimulate Lim kinases (LIMKs). LIMKs phosphor-
ylate cofilin, thereby preventing actin depolymerization (32). We
reasoned that chronic mTORC2 activity might inhibit lysosome
acidification through a cofilin-dependent mechanism. In unsti-
mulated MRL/lpr Mws, the basal levels of p-cofilin were 1.5-fold
higher than B6 (Fig. 3A, Supplemental Fig. 2A). After stimulation
with IgG-ICs, p-cofilin levels were 2.4-fold higher than B6, a
result confirmed by immunoblot (Fig. 3B, 3C). Further, inhibiting
LIMK (LIMKi 3) (32), or mTORC1/C2 (Torin1) in MRL/lprMws,
reduced p-cofilin to levels comparable to B6 (Fig. 3A). In contrast,
rapamycin (mTORC1 inhibitor) had no effect. Thus, chronic
mTORC2 activity heightens cofilin phosphorylation. Because
actin affects cellular motility, and chronic mTORC2 activity
FIGURE 1. Lupus-prone Mws have heightened and mislocalized mTOR activity. (A and B) Cell lysates from unstimulated and stimulated (1 h) BMMws
(1–1.5 3 106 cells) were immunoblotted with the indicated proteins; four experiments (exp) were conducted using four mice. Densitometry values were
normalized to tubulin and relative to B6. (C and D) Unstimulated BMMws treated 6 Torin1 (250 nM) for 2 h were examined by confocal imaging for
mTOR localization with CD11b (scale bar, 10 mm); three exp were conducted using three mice and 30 cells. (E) Unstimulated BMMws were cultured 6
Torin1 (250 nM) for 2 h, and the levels of mTOR were assessed by flow cytometry; three exp were conducted using three mice. The MFI was normalized to
the isotype control and relative to untreated B6. Data are presented as mean 6 SEM. *p # 0.05, **p # 0.01, ***p # 0.001.
prevents actin depolymerization (28), we predicted that MRL/lpr
Mws may exhibit decreased membrane ruffling and/or cell mi-
gration. Imaging of MRL/lpr Mws showed that membrane ruffling
(Supplemental Fig. 2B–D) and Mw migration (Supplemental Fig.
2E–H) were decreased. This is consistent with previous findings
that mobility of lupus-prone Mws is decreased following exposure
to lipids and/or apoptotic debris (33–35).
Cofilin attaches to F-actin and promotes depolymerization (36),
whereas phosphorylation of cofilin prevents its association with
actin, thereby stabilizing actin filaments (32). In MRL/lpr Mws,
active mTOR localizes to the cell membrane (Fig. 1C, 1D), co-
inciding with increased levels of p-cofilin (Fig. 3A). We reasoned
that mTORC2 activity at the membrane could increase the local
levels of p-cofilin, thereby decreasing the association of cofilin
with actin that surrounds phagocytic vesicles. To assess this, we
stimulated Mws with IgG-ICs and found that 3.9-fold more cofilin
localized to IgG-IC–containing vesicles in B6 Mws compared with
MRL/lpr (Fig. 3D, 3E). In addition, the cofilin that localized to
IgG-IC–containing vesicles in B6 Mws was rarely phosphorylated.
Conversely, 2.7-fold more p-cofilin localized with IgG-IC–containing
vesicles in MRL/lpr Mws, indicating that cofilin phosphorylation
occurs in proximity to the vesicle.
Our findings support a model where mTORC2-mediated phos-
phorylation of cofilin reduces its associationwith phagocytic vesicle. If
the association of cofilin to vesicular actin was important in lysosome
acidification, then preventing cofilin localization to actin filaments
should inhibit lysosome acidification in B6 Mws. JasP stabilizes actin
by binding directly to F-actin, thereby preventing cofilin associ-
ation (37). B6 Mws treated with JasP showed diminished acidi-
fication, similar to MRL/lpr, suggesting an important role for
cofilin localization with the phagosome in lysosome acidification
(Fig. 3F). Conversely, we predicted that decreasing p-cofilin levels
in MRL/lpr Mws would restore cofilin localization and subsequent
lysosome acidification. Indeed, treating MRL/lpr Mws with
LIMKi 3 restored lysosome acidification to levels comparable to
B6 (Fig. 3F). These data implicate chronic mTORC2 activity in
constitutively phosphorylating cofilin, which disrupts lysosome
acidification.
Cofilin allows caspase-11 to associate with vesicles
Although caspases are strongly associated with cell death (38), they
have alternative roles (9, 10, 39). For example, the CARD domain
of caspase-11 associates with AIP-1 and cofilin and facilitates
actin depolymerization (40). This raises the possibility that the
association of caspase-11 with cofilin might be necessary for ly-
sosome acidification. To test this, we immunoprecipitated caspase-
11 and quantified the levels of associated cofilin. In unstimulated
B6 and MRL/lpr Mws, the levels of caspase-11 that bound to
cofilin were comparable (Fig 4A, 4B). In contrast, stimulation
with IgG-ICs induced 2.5-fold more caspase-11 to bind cofilin in
B6 Mws compared with MRL/lpr. This was not due to increased
caspase-11 expression (Fig 4A, 4C). Interestingly, p-cofilin levels
FIGURE 2. Chronic mTORC2 activity impairs lysosome acidification and degradation of IgG-ICs. BMMws treated for 2 h 6 Torin1 (250 nM) or 6
rapamycin (100 ng/ml) were stimulated with IgG-ICs while remaining on treatment. (A) Lysosome pH was assessed by ratiometric flow cytometry at
indicated time points; 13 experiments (exp) were conducted using 3–14 mice. (B) Recycling of surface IgG-ICs assessed by flow cytometry 72 h post-
stimulation; five to six exp were conducted using five to six mice. (C) BMMws were stimulated with IgG-ICs (small; representing apoptotic blebs bound by
IgG) or WC-ICs (big; representing intact apoptotic cells bound by IgG), and LC3A levels were measured by flow cytometry; seven exp were conducted
using seven mice. MFI was normalized to the isotype control and relative to unstimulated B6. (D) BMMws treated for 2 h 6 Torin1 (250 nM) or 6
rapamycin (100 ng/ml) were stimulated with WC-ICs (big) while remaining on treatment. Lysosome pH was assessed by ratiometric flow cytometry at
indicated time points; four exp were conducted using four mice. Data are presented as mean 6 SEM. *p # 0.05, **p # 0.01, ***p # 0.001.
were undetectable, indicating that caspase-11 only associates with
unphosphorylated cofilin (Fig. 4A). Thus, following phagocytosis
of IgG-ICs, caspase-11 recruits to unphosphorylated cofilin.
Signaling effectors are normally recruited to phagosomal structures
(11, 41). Therefore, proteins critical to lysosome acidification could
also localize to vesicles containing IgG-ICs. Because cofilin associates
with vesicles containing IgG-ICs (Fig. 3D, 3E), and caspase-11 is
recruited to cofilin following stimulation with IgG-ICs (Fig. 4A–C), we
hypothesized that caspase-11 could localize to vesicles containing IgG-
IC. In B6 Mws, we observed multiple instances of caspase-11 asso-
ciation with vesicles containing IgG-ICs, but in MRL/lpr Mws,
caspase-11 association was reduced 3-fold (Fig. 4D, 4E). This was
not due to decreased caspase-11 expression (Fig. 4A, 4C). Further,
caspase-11 retains its ability to associate with actin structures in
MRL/lpr Mws because we found significant colocalization of
caspase-11 with actin that was not localized at vesicles containing
IgG-ICs (Fig. 4D, 4E). This indicates that caspase-11 association
with actin structures is not broadly impaired in MRL/lpr Mws. In
addition, impairing the phosphorylation of cofilin (LIMKi 3) and
the activity of mTORC1/C2 (Torin1) in MRL/lprMws restored the
localization of caspase-11 to the vesicles containing IgG-ICs,
whereas rapamycin had no effect (Fig. 4E, Supplemental Fig.
3A). This corroborates a role for chronic mTORC2 activity in
preventing the association of caspase-11 with phagocytic vesicles
when active LIMK phosphorylates cofilin.
Previous studies found that caspase-11 is important in lysosome
acidification following phagocytosis of bacteria (9); however, the
underlying mechanisms remain unclear. We found that caspase-11
recruits to vesicles containing IgG-ICs and that chronic mTORC2
activity in MRL/lpr Mws prevents caspase-11 localization to the
phagosome (Fig. 4D, 4E, Supplemental Fig. 3A). We reasoned
that if caspase-11 were involved in lysosome acidification,
BMMws from B6.caspase-112/2 mice (Casp112/2) would show
impaired acidification following phagocytosis of IgG-ICs. Lyso-
some acidification in Casp112/2 Mws was impaired, with pH
levels comparable to MRL/lpr (Fig. 4F). Together, these results
demonstrate that localization of caspase-11 to phagocytic vesicles
via cofilin is necessary to acidify the lysosome.
FIGURE 3. Chronic mTORC2 activ-
ity phosphorylates cofilin (cof), impairing
lysosome acidification. (A) BMMws
treated for 2 h 6 Torin1 (250 nM), 6
rapamycin (100 ng/ml), or 6 LIMKi 3
(3 mM) were stimulated with IgG-ICs
while remaining on treatment. At the
indicated time points, p-cofilin (p-cof)
levels were measured by flow cytometry;
ten experiments (exp) were conducted
using three to ten mice. MFI was nor-
malized to the isotype control, and p-cof
was normalized to total cof. (B and C)
Cell lysates from BMMws (1–1.5 3 106
cells) stimulated with IgG-ICs (30 min)
were measured by immunoblot; three
exp were conducted using three mice.
Densitometry values were normalized
to tubulin and relative to B6. (D and E)
BMMws stimulated with IgG-ICs
(15 min) were examined by confocal
imaging in three dimensions for the
localization of p-cof and cof with actin
and IgG-ICs (scale bar, 5 mm); three
exp were conducted using three mice
and 13–14 cells. Colocalization was
measured across the entire cell volume.
(F) BMMws treated for 1 h 6 JasP
(2 mM) or 2 h 6 Torin1 (250 nM), 6
rapamycin (100 ng/ml), or 6 LIMKi 3
(3 mM) were stimulated with IgG-ICs
while remaining on treatment. Lyso-
some pH was assessed by ratiometric
flow cytometry at indicated time points;
four exp were conducted using four mice.
Data are presented as mean 6 SEM.
*p# 0.05, **p# 0.01, ***p# 0.001.
Caspase-11 recruitment to vesicles results in
inflammasome-independent activation of caspase-1
Caspase-1 has been implicated in lysosome acidification after
phagocytosis of bacteria, suggesting a role for caspase-1 beyond
activation following inflammasome formation (10). Caspase-11
physically interacts with, and activates, caspase-1 (42). Therefore,
the association of caspase-11 with phagocytic vesicles might locally
activate caspase-1 upstream of lysosome acidification. Using im-
munoprecipitation, we assessed whether caspase-1 associates with
caspase-11. Stimulation of B6 Mws with IgG-ICs increased the
association of caspase-1 with caspase-11 by 1.8-fold compared with
MRL/lpr (Fig. 5A, 5B). This indicates that caspase-1 associates
with caspase-11 in B6 Mws following phagocytosis of IgG-ICs. In
contrast, caspase-1 association with caspase-11 in MRL/lpr Mws is
impaired.
Stimulation of B6 Mws recruits caspase-1 to caspase-11, coin-
cident with a 2.1-fold increase in caspase-1 activity (Fig. 5C). In
contrast, stimulation of MRL/lpr Mws does not increase caspase-1
activity. To corroborate this result, we stimulated B6 and MRL/lpr
Mws with IgG-ICs, then immunoblotted lysates for the levels of
caspase-1 p20 subunit (readout for caspase-1 activity). The p20
subunit was increased 4.3-fold in B6 Mws compared with MRL/lpr
(Fig. 5D, 5E). In addition, stimulation with IgG-ICs did not acti-
vate caspase-1 in BMMws from Casp112/2 and B6.caspase-12/2
caspase-112 /2 mice (Casp12 /2Casp112 /2) (Fig. 5C). Thus,
following phagocytosis, active caspase-1 associates with caspase-11
in B6 Mws. However, association and activation are impaired in
MRL/lpr Mws.
Apoptosis-associated speck-like protein containing a caspase re-
cruitment domain (ASC or Pycard) facilitates caspase-1 activation
during inflammasome formation (18). To determine whether caspase-1
activation on the phagosome requires inflammasome formation, we
measured the levels of active caspase-1 in BMMws from B6.pycard2/2
mice (Asc2/2). Phagocytosis of IgG-ICs activated caspase-1 in Asc2/2
Mws to levels similar to B6 (Fig. 5C). This demonstrates that caspase-1
activation following phagocytosis is independent of ASC-mediated
inflammasome formation but requires caspase-11. Consistent
with activation of caspase-1 and caspase-11 being independent of
pyroptosis, the activation of caspase-1 and recruitment of caspase-11
to the vesicles containing IgG-ICs did not result in cell death because
B6 Mws survived for over 72 h following phagocytosis (13).
Caspase-11 is integral to lysosome acidification (Fig. 4F) and
necessary in activating caspase-1 following phagocytosis (Fig. 5C–E).
Further, the correct localization of caspase-11 requires cofilin
(Fig. 4E, Supplemental Fig. 3A). To assess whether these events
were linked, we altered the function of cofilin and measured
caspase-1 activation following stimulation of Mws with IgG-IC.
Impairing the association of cofilin with actin (JasP) reduced
caspase-1 activation in B6 Mws to levels comparable to MRL/lpr
(Fig. 5F). Conversely, inhibiting cofilin phosphorylation (LIMKi 3)
FIGURE 4. Phosphorylation of cofilin prevents caspase-11 localization with vesicles, which impairs lysosome acidification. (A–C) BMMws were
stimulated with IgG-ICs (30 min). Caspase-11 was immunoprecipitated (5–9 3 106 cells), and bound proteins were quantified by immunoblot; 5 ex-
periments (exp) were conducted using three to five mice. Densitometry values were normalized to immunoprecipitated levels of caspase-11. (D and E)
BMMws treated for 2 h 6 Torin1 (250 nM),6 rapamycin (100 ng/ml), or6 LIMKi 3 (3 mM) were stimulated for 15 min with IgG-ICs while remaining on
treatment and were examined by confocal imaging in three dimensions for the localization of caspase-11 with actin and IgG-ICs (scale bar, 5 mm); three
exp were conducted using three mice and 10–16 cells. Colocalization was measured across the entire cell volume. See Supplemental Fig. 3A for images of
cells treated with LIMKi 3 and rapamycin. (F) BMMws were stimulated with IgG-ICs, and lysosome pH was assessed by ratiometric flow cytometry at
indicated time points; eight exp, five to eight mice. Data are presented as mean 6 SEM. ns: p . 0.05, *p # 0.05, **p # 0.01, ***p # 0.001.
restored caspase-1 activation in MRL/lpr Mws to B6 levels. These
results demonstrate that caspase-1 activation is dependent on the
association of cofilin with actin.
Our data show that chronic mTORC2 activity and heightened
phosphorylation of cofilin, mislocalize caspase-11 in MRL/lpr
Mws (Fig. 4E, Supplemental Fig. 3A). Further, phagocytosis in
MRL/lpr Mws did not localize caspase-1 to caspase-11 (Fig. 5A,
5B) or activate caspase-1 (Fig. 5C). Thus, it is possible that
inhibiting mTORC2 might restore caspase-1 activation. Therefore,
we treated MRL/lpr Mws with Torin1 and stimulated them with
IgG-ICs. Torin1 treatment increased caspase-1 activation 2-fold to
levels seen in B6 Mws (Fig. 5G). In contrast, treatment with
rapamycin did not restore caspase-1 activity in MRL/lpr Mws.
This demonstrates that chronic mTORC2 activation limits caspase-1
activation following phagocytosis.
Because phagocytosis localizes caspase-11 to phagocytic vesi-
cles (Fig. 4D, 4E) and activates caspase-1 (Fig. 5C–E), we rea-
soned that caspase-1 likely becomes activated in the proximity of
vesicles containing IgG-ICs. Imaging showed that 3-fold more
active caspase-1 localized with IgG-ICs in B6 Mws compared with
MRL/lpr (Fig. 5H, 5I). Torin1 treatment restored the localization
of active caspase-1 with IgG-ICs in MRL/lpr Mws to levels
comparable to B6 (Fig. 5H, 5I). This is consistent with mTORC2
being upstream of caspase activation and reveals that phagocytosis
initiates activation of caspase-1 proximal to phagocytic vesicles.
Although 80–90% of MRL/lpr Mws examined by microscopy
showed low levels of caspase activation, there were rare cells that
showed elevated levels of active caspase-1. In these instances,
active caspase-1 was localized in the cytosol and did not coloc-
alize with IgG-ICs. This staining pattern is consistent with
FIGURE 5. Mislocalization of caspase-11 prevents localized caspase-1 activation, thereby impairing lysosome acidification. (A and B) BMMws were
stimulated with IgG-ICs (30 min), and caspase-11 was immunoprecipitated (5–9 3 106 cells). Bound proteins were quantified by immunoblot; five ex-
periments (exp) were conducted using five mice. Densitometry values were normalized to levels of immunoprecipitated caspase-11. (C) BMMws were
stimulated with IgG-ICs (30 min) and assessed for caspase-1 activation by flow cytometry; six exp were conducted using two to six mice. MFI of active
caspase-1 is relative to unstimulated B6. (D and E) Cell lysates from BMMws (4–4.5 3 106 cells) stimulated with IgG-ICs (30 min) were immunoblotted;
four exp were conducted using four mice. Densitometry values were normalized to tubulin. (F and G) BMMws treated for 1 h 6 JasP (2 mM) or 2 h 6
Torin1 (250 nM), 6 rapamycin (100 ng/ml), or 6 LIMKi 3 (3 mM) were stimulated with IgG-ICs (30 min) while remaining on treatment and assessed for
caspase-1 activation by flow cytometry; six exp were conducted using two to six mice. MFI of active caspase-1 is relative to unstimulated B6. (H and I)
BMMws treated 6 Torin1 for 2 h were stimulated with IgG-ICs (15 min) while remaining on treatment and were examined by confocal imaging to assess
the localization of active caspase-1 with IgG-ICs (scale bar, 5 mm); three exp were conducted using three mice and 15–42 cells. (J) BMMws stimulated with
IgG-ICs and lysosome pH was assessed by ratiometric flow cytometry at indicated time points; nine exp were conducted using two to nine mice. Data are
presented as mean 6 SEM. ns: p . 0.05, *p # 0.05, **p # 0.01, ***p # 0.001. Casp-1, caspase-1.
inflammasome formation (Supplemental Fig. 3B) and supports our
previous data, showing that impaired lysosome maturation in
MRL/lpr Mws allows nucleic acids from the IgG-ICs to leak into
the cytosol and induce inflammasome formation (13).
To determine whether caspase-1 activation is necessary for ly-
sosome acidification, we quantified the vesicular pH in BMMws
from B6.caspase-12/2caspase-11tg (Casp12/2) mice after stimu-
lation with IgG-ICs. Both Casp12/2Casp112/2 and Casp12/2
Mws exhibited impaired lysosome acidification with pH levels
comparable to MRL/lpr (Fig. 5J). Similarly, inhibiting caspase-1
with VAD-FMK prevented lysosome acidification in B6 Mws
(Supplemental Fig. 3C). The role of caspase-1 in lysosome acid-
ification was inflammasome-independent, as Asc2/2 Mws achieve
a pH comparable to B6 (Fig. 5J). It is important to note that
Casp12/2 and Casp112/2 mice fail to develop spontaneous
SLE despite having impaired lysosome acidification. Chronic
mTORC1 activity in MRL/lpr Mws (Fig. 1A, 1B) could impair
autophagy. As such, Casp12/2 and Casp112/2 Mws could use
autophagic processes to degrade phagocytosed IgG-ICs when
primary lysosome acidification fails (Supplemental Fig. 3D).
Overall, this demonstrates that the localization of active caspase-
1 with phagocytic vesicles is necessary to acidify the lysosome
but is independent of inflammasomes.
Cleavage of Rab39a by caspase-1 is necessary for
lysosome acidification
The association of Rab GTPases with specificmembranes is critical
for phagocytosis, vesicular trafficking, and exocytosis (1). Al-
though the function of Rab39a is relatively uncharacterized, its
subcellular localization suggests a role in endocytic pathways
(43). Further, expression of a dominant-negative Rab39a prevents
lysosome acidification (44), and Rab39a contains a functional
caspase-1 cleavage site (45). Therefore, localization of active
caspase-1 to phagocytic vesicles (Fig. 5H, 5I) could cleave
Rab39a, leading to lysosome acidification. To assess this, we
immunoprecipitated Rab39a and immunoblotted for full-length
Rab39a and the 17-kDa N-terminal cleavage product. Following
phagocytosis of IgG-ICs, B6 Mws cleaved 9.6-fold more Rab39a
compared with MRL/lpr Mws (Fig. 6A–C).
Commercial Abs to Rab39a are limited, and they fail to spatially
resolve Rab39a within the cell (data not shown). Therefore, we
constructed FLAG- and HA-tagged versions of Rab39a (Fig. 6D), a
Rab39a point mutant where Asp148 in the caspase-1 cleavage site
was replaced by Ala (Rab39aD148A) to prevent caspase-1
cleavage (45) and the Rab39a[NT] and Rab39a[CT] caspase-1
cleavage products.
To define the role of Rab39a during vesicular trafficking, we
transduced BMMws with wild type and mutant forms of Rab39a
and then used microscopy to monitor their localization relative
to internalized IgG-ICs. In B6 BMMws transduced with the
uncleavable Rab39aD149A, both the HA and FLAG tags colocalized
with IgG-ICs (Fig. 6E; representative images in Supplemental Fig 4A),
consistent with the D149A mutation-impairing cleavage by
caspase-1. In contrast, B6 BMMws transduced with wild type
Rab39a showed that the FLAG tag (C terminus) colocalized with
IgG-ICs, whereas the HA tag (N terminus) showed a 2.1-fold re-
duction in colocalization with IgG-ICs. Therefore, Rab39a is
cleaved in B6 Mws with the C-terminal fragment remaining on
FIGURE 6. Failed cleavage of Rab39a by casapase-1 impairs lysosome acidification. (A–C) BMMws were stimulated for 30 min with IgG-ICs, and
Rab39a was immunoprecipitated (15–20 3 106 cells). Full-length (FL) Rab39a, or Rab39a cleavage product were quantified by immunoblot; three ex-
periments (exp) were conducted using three mice. (D) Image showing the constructs used in retroviral transduction of BMMws. Arrows point to caspase-1
cleavage site. (E) Transduced BMMws treated for 2 h 6 Torin1 (250 nM) were stimulated with IgG-ICs (20 min) while remaining on treatment. The
confocal images showing the colocalization of Rab39a with IgG-ICs is quantified in (E), with representative images of the cells shown in Supplemental Fig.
4A; three exp were conducted using three mice and 16–21 cells. (F) Transduced BMMws were stimulated with IgG-ICs. Lysosome pH was assessed in
transduced (GFP+) and nontransduced (GFP2) Mws over time using ratiometric flow cytometry; three exp were conducted using three mice. Data are
presented as mean 6 SEM. ns: p . 0.05, *p # 0.05, **p # 0.01, ***p # 0.001.
the vesicle, and the N terminus dispersing into the cytosol. In MRL/
lpr BMMws expressing wild type Rab39a, a different phenotype was
evident. We found that the HA (N terminus) and FLAG (C terminus)
tags remained colocalized with IgG-ICs (Fig. 6E, Supplemental Fig.
4A). This was much like B6 Mws expressing uncleavable
Rab39aD148A, indicating that MRL/lprMws fail to efficiently cleave
Rab39a. To assess whether cleavage of Rab39a could be restored by
inhibiting mTOR activity, we treated MRL/lpr Mws with Torin1.
Inhibiting mTOR reduced the colocalization of the HA tag (N ter-
minus) with IgG-ICs by 1.6-fold (Fig. 6E, Supplemental Fig. 4A).
This indicates that heightened mTOR activity disrupts the cleavage of
Rab39a, coincident with diminished caspase-1 activation (Fig. 5G).
To assess whether the N or C terminus of Rab39a is required for
acidification, we transduced MRL/lpr Mws with Rab39a[CT] or
Rab39a[NT]. Cells expressing Rab39a[CT] showed the FLAG tag
(C terminus) colocalized with IgG-ICs, whereas cells expressing
Rab39a[NT] showed a 4.4-fold decrease in the colocalization of
the HA tag (N terminus) with IgG-ICs when compared with MRL/lpr
Mws expressing wild type Rab39a (Fig. 6E). This corresponded with
a diffuse cytosolic staining pattern (Supplemental Fig. 4A). The
ability of the C terminus of Rab39a, but not the N terminus, to
associate with the phagosomal membrane is consistent with previ-
ous studies showing that prenylation motif in the C terminus of Rab
proteins is necessary for membrane association (46).
Although a dominant-negative form of Rab39a prevents lysosome
acidification (44), and the caspase-1 cleavage site in Rab39a is
functional in vivo (45), cleavage of Rab39a by caspase-1 has never
been associated with lysosome acidification. Like nontransduced B6
Mws, those expressing wild type Rab39a showed a 36% decrease in
pH after IgG-IC stimulation (Fig. 6F, gating scheme in Supplemental
Fig. 4B). In contrast, B6 Mws expressing uncleavable Rab39aD148A
showed a 13% decrease in pH. This indicates that caspase-1 cleavage
of Rab39a is necessary for lysosome acidification.
To define which Rab39a fragment was associated with lysosome
acidification, we measured the ability of MRL/lpr Mws expressing
either the N- or C-terminal Rab39a cleavage products to acidify.
MRL/lprMws expressing Rab39a[CT] showed a 36% decrease in pH
upon IgG-IC stimulation, which is comparable to B6 (Fig. 6F). In
contrast, neither full-length wild type Rab39a nor Rab39a[NT] res-
cued lysosome acidification, achieving a 13–14% decrease in pH.
This indicates that the C-terminal fragment of Rab39a can rescue
the lysosome defect in MRL/lpr Mws and thus is sufficient to acid-
ify the lysosome. The inability of MRL/lprMws to activate caspase-1
in the proximity of phagocytic vesicles (Fig. 5H, 5I) impairs Rab39a
cleavage, which is necessary for lysosome acidification [see model
(Fig. 7)].
Discussion
This study defines a previously unappreciated role for actin-
dependent caspase-1 activation in lysosome acidification. In wild
type Mws, binding of IgG-ICs to FcgRI transiently increases
mTORC2 activity, allowing cofilin to associate with the actin that
surrounds phagocytic vesicles (phagosomes) containing the in-
ternalized IgG-ICs (Fig. 7). Cofilin subsequently recruits caspase-
11, which, in turn, activates caspase-1 in proximity of the
phagosome. Activated caspase-1 cleaves Rab39a, allowing its
C-terminal fragment to promote lysosome acidification. This
process is impaired in Mws from lupus-prone mice. MRL/lpr Mws
exhibit chronic mTORC2 activity as part of a feedforward loop in
which diminished lysosome acidification and recycling of IgG-ICs
bound by FcgRI leads to chronic FcgRI signal transduction
(Fig. 1A, 1B; (13, 14). Heightened mTORC2 activity increases the
phosphorylation of cofilin; a form of cofilin that fails to associate
with or depolymerize actin (Fig. 7). This disrupts the localization
of caspase-11 with actin and prevents activation of caspase-1 at the
phagocytic vesicle. As a result, Rab39a remains intact and lyso-
some acidification is impaired. Thus, in lupus-prone Mws, im-
paired lysosome acidification prevents the degradation of IgG-ICs
through sustained FcgRI signal transduction, creating a feedfor-
ward loop that promotes lupus-associated pathologies (13–15).
Autophagy is an alternative form of lysosomal degradation that
primarily degrades damaged organelles and cytosolic proteins.
FIGURE 7. Model depicting the signaling events
regulating lysosome acidification in B6 Mws (left)
and the signaling defects associated with impaired
lysosome acidification in lupus-prone MRL/lpr Mws
(right).
binding additional activating receptors, leading to heightened cel-
lular activation (13). The mechanisms of how these two FcgRI li-
gands confer protection versus pathologic conditions remain to be
elucidated. Regardless, FcgRI-mediated signal transduction links
incoming cargo to lysosome acidification.
Collectively, our studies show that accumulation of nuclear Ags
on the surface of hematopoietic cells in murine SLE occurs prior to
the onset of disease, is not unique to MRL/lpr mice, is not a
consequence of Fas, and is not simply due to an increased burden
of apoptotic cells (14). Biologically, lysosome dysfunction im-
pacts disease at several levels. First, studies in FcgRI2/2MRL/lpr
mice and passive transfer of pathogenic IgG antinucleosome into
AID2/2MRL/lpr mice show that lysosome dysfunction is up-
stream of BAFF and IFN-a secretion, B cell activation, autoan-
tibody production, migration of cells to the kidney, and renal
disease (14, 15). This suggests that lysosome dysfunction is a
“branch-point” upstream of multiple SLE-related pathologies.
Second, defective degradation of IgG-ICs prolongs the exposure
of endosomal TLRs to their ligands that are exposed on apoptotic
debris/blebs. Diminished degradation of internalized IgG-ICs also
permeabilizes the phagolysosomal membrane, allowing intact
IgG-ICs to leak into the cytosol and activate innate receptors,
heightening cell death and producing IFN-a (13). This provides an
explanation for how cytosolic innate immune sensors become
activated and contribute to SLE. This study identifies a previously
unappreciated signaling pathway that regulates lysosome acidifi-
cation and shows how lysosome dysfunction is linked to chronic
FcgRI signal transduction and subsequent mTORC2 activity. We
show that chronic mTORC2 activity disrupts assembly of caspase-11/
caspase-1/Rab39a, a critical enzyme complex involved in lysosome
acidification that normally assembles on the actin surrounding
the phagolysosome. When this pathway is disrupted, incoming
IgG-ICs are unable to be degraded and subsequently recycle to the
cell surface. This creates a feedforward loop wherein chronic FcgR
signaling, through heightened mTORC2 activity and disrupted as-
sembly of caspase11/caspase1/Rab39a, attenuates lysosomal acidifi-
cation. Thus, diminished lysosomal acidification and recycling of
FcgRI-bound IgG-ICs result from, and lead to, chronic FcgR sig-
naling. It is noteworthy that sustained signal transduction through
FcgRI also activates mTORC1 (Fig. 1A, 1B). This may prevent
autophagy from compensating for diminished lysosome degradation
(28) and further cripple the clearance of inflammatory IgG-ICs.
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NADPH oxidase activity controls phagosomal proteolysis in macrophages
When impaired lysosomal acidification diminishes degradation of 
cargo in phagosomes, it is possible that autophagy can compensate 
by degrading immature phagolysosomes. Although Mws from 
Casp112/2 mice exhibited diminished lysosome acidification, 
they do not develop SLE. However, they expressed high levels of 
LC3A (Supplemental Fig. 3D) consistent with autophagosome 
formation. In contrast, LC3A was not elevated in MRL/lpr Mws, 
indicating that lupus-prone Mws do not use autophagy, despite 
loss of lysosomal degradation. This could be a consequence of 
heightened mTORC1 activity (Fig. 1A, 1B) because mTORC1 has 
been shown to inhibit the assembly of autophagosomes (29), and 
mTORC1 is heightened in MRL/lpr Mws as a consequence of 
chronic FcgRI signal transduction (Fig. 1A, 1B).
Our finding that activated caspase-1 was required for lysosome 
acidification was unexpected. Caspase-1 activation has historically 
been associated with inflammasomes and pyroptosis (17). Our 
findings reveal that caspase-1 also plays a critical role in lysosome 
acidification. Although it remains possible that NLRC4 or NLRP1b 
(CARD-containing receptors that don’t require ASC for cell death) 
contribute to caspase-1 activity (47, 48), this scenario is unlikely 
because CARD-containing receptors still require ASC for down-
stream signal transduction (49). We do not believe CARD-containing 
receptors activate caspase-1 during lysosome acidification because 
they initiate pyroptosis (47, 48), yet we find that B6 Mws that  
phagocytosed IgG-ICs survive longer than 72 h (13). However, 
this raises the following question: Why does activation of caspase-1 
during lysosome acidification not promote cell death? One possi-
bility is that varying levels of active caspase-1 promote different 
outcomes. Perhaps low levels of active caspase-1 induce lysosome 
acidification, whereas high levels drive pyroptosis. In support 
of this graded response, other studies show that low levels of 
caspase-3 or -8 activation regulate autophagic cell death, dif-
ferentiation and proliferation of T and B cells, and maturation 
of dendritic cells (39), whereas high levels of activation promote 
apoptosis (38). Alternatively, localizing activated caspase-1 to 
vesicles (Fig. 5H, 5I) might restrict its activity near Rab39a on 
vesicular membranes. The importance of caspase-1 localization 
to its function has already been demonstrated in the context 
of pyroptosis, as localizing gasdermin D near the developing 
inflammasome directs its cleavage by caspase-1 (50). Localizing 
caspase-1 to vesicular membranes to promote lysosome acidifi-
cation could further benefit the cell by heightening its pyroptotic 
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